Diligence memo · auto-generated · as of July 2, 2026
Telesis Bio Inc.
Telesis Bio Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Telesis Bio Inc. operates in Biotech / Pharma, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Telesis Bio Inc. has raised $28M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $28M on 2023-06-05.
Most recent recorded round closed around 2023-06-05.
Valuation (modeled)modeled
Provath models Telesis Bio Inc. at approximately $308M (range $57M–$678M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.17× the median modeled value of Series B Biotech / Pharma companies in 2022–2024 (15 peers) — value vs value, same stage and era. Within the normal band (117% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 3.1 yr ago; this sector typically re-raises about every 15 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 81% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: Carbon Biosciences, Inc., Slingshot Biosciences, Inc., Nueva Bio LLC, Turn Biotechnologies, Inc., Surf Bio, Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.